marijuana stock news

Nabis Holdings Announces OTC Ticker Symbol Change to “NABIF”

 Nabis Holdings Inc. (NAB.CN) (INNPF) (OTC:NABIF) (FRA:A2PL) (“Nabis™” or the “Company”), a leading Canadian investment company with specialty investments in assets across multiple divisions of the cannabis sector, today announced that the Financial Industry Regulatory Authority, Inc. (“FINRA”) has approved the Company’s request to change its OTC ticker symbol to “NABIF,” effective as of the opening of market trading today on June 20, 2019. The previous trading symbol was “INNPF.”

“Trading under the new OTC ticker ‘NABIF’ completes our corporate transition to Nabis. With our public company presence now fully aligned to our corporate brand, we are excited to continue to build the Nabis footprint across the United States,” said Shay Shnet, CEO & Director of Nabis.

In addition, the Company will continue to trade on the Canadian Stock Exchange under “NAB” as well as on the Frankfurt Stock Exchange under “A2PL.”

There is no action required by current shareholders in connection with this change.

About Nabis Holdings Inc.
Nabis Holdings is a Canadian investment issuer that invests in high quality cash flowing assets across multiple industries, including real property, securities, cryptocurrency, and all aspects of the U.S. and international cannabis sector. Led by two of the co-founders of MPX Bioceutical, one of the largest takeovers in the U.S. Cannabis space to date, the company has a proven track record in emerging markets to create significant shareholder value. The Company is focused on investing across the entire vertically integrated aspects of the space with a focus on revenue generation, EBITDA and growth.

For more information, please visit

Forward-Looking Statements
All statements, other than statements of historical fact, included herein are forward-looking statements that involve various risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. The risks are without limitations: that the acquisitions will be completed by the Company or completed upon the terms disclosed; the price for cannabis and related products will remain consistent and the consumer demand remains strong; availability of financing to the Company to develop the retail locations; retention of key employees and management; changes in State and/or municipal regulations of retail operations and changes in government regulations generally. Important factors that could cause actual results to differ, materially from the Company’s expectations are disclosed in the Company’s documents filed from time to time with the Canadian Securities Exchange, the British Columbia Securities Commission, the Ontario Securities Commission and the Alberta Securities Commission.

The CSE does not accept responsibility for the adequacy or accuracy of this release.

For inquiries, please contact:

Investor Contact:
Allison Soss
KCSA Strategic Communications
PH: 212-896-1267

Company Contact:
Shay Shnet, CEO and Director
PH: 604-687-7130

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 |
Leave a Reply

Your email address will not be published.

You May Also Like

$VHUB Pays Second Installment Of Interest

Vapor Hub International Pays Second Installment Of Interest, Fees Due on Promissory…

$TRTC Financials and Shareholder Update for Quarter Ending Sept 30th, 2014

Terra Tech Releases Financials for the Quarter Ending September 30, 2014, Updates…

InMed Pharmaceuticals Inc. (IMLFF) to Present at the 8th Annual LD Micro Invitational Conference

InMed to Present at the 8th Annual LD Micro Invitational Conference InMed…

GW Pharmaceuticals (GWPH) Reports Financial Results and Operational Progress for the Second Quarter Ended June 30, 2019

– Epidiolex U.S. Q2 net sales of $68.4 million – – Positive…